These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26317036)

  • 1. Diagnosis of Non-ST-Elevation Acute Coronary Syndrome by the Measurement of Heart-Type Fatty Acid Binding Protein in Serum: A Prospective Case Control Study.
    Chandran PA; Wani BA; Satish OS; Mohammed N
    J Biomark; 2014; 2014():624930. PubMed ID: 26317036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.
    Çavuşoğlu Y; Gök B; Demirüstü C; Birdane A; Görenek B; Ata N
    Anadolu Kardiyol Derg; 2012 Nov; 12(7):584-90. PubMed ID: 22804980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
    Bank IE; Dekker MS; Hoes AW; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; Timmers L; de Kleijn DP; Glatz JF; Mosterd A
    Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):364-74. PubMed ID: 25906779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.
    Willemsen RT; van Severen E; Vandervoort PM; Grieten L; Buntinx F; Glatz JF; Dinant GJ
    Eur J Gen Pract; 2015; 21(3):156-63. PubMed ID: 25751665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of a 4,183 Da peptide of dermcidin protein in the early diagnosis and differential diagnosis of acute coronary syndrome].
    Kai F; Lifeng L; Haijing S; Xianhua L; Hu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Dec; 27(12):970-4. PubMed ID: 27318339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
    Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
    Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
    Figiel Ł; Wraga M; Bednarkiewicz Z; Lipiec P; Smigielski J; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2011; 69(1):1-6. PubMed ID: 21267954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart fatty acid-binding protein in combination with the 80-lead body surface potential map improves early detection of acute myocardial infarction in patients who are cardiac troponin T-negative at presentation.
    Daly MJ; McCann CJ; Owens CG; Harbinson MT; Adgey JA
    J Electrocardiol; 2011; 44(4):432-8. PubMed ID: 21529821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome.
    Ishii J; Ozaki Y; Lu J; Kitagawa F; Kuno T; Nakano T; Nakamura Y; Naruse H; Mori Y; Matsui S; Oshima H; Nomura M; Ezaki K; Hishida H
    Clin Chem; 2005 Aug; 51(8):1397-404. PubMed ID: 15951316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury].
    Li Z; Cui S; Geng L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):443-448. PubMed ID: 34053488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department.
    Charpentier S; Ducassé JL; Cournot M; Maupas-Schwalm F; Elbaz M; Baixas C; Juchet H; Lang T; Lauque D
    Acad Emerg Med; 2010 Jan; 17(1):27-35. PubMed ID: 20078436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care.
    Bruins Slot MH; Rutten FH; van der Heijden GJ; Doevendans PA; Mast EG; Bredero AC; van der Spoel OP; Glatz JF; Hoes AW
    Int J Cardiol; 2013 Sep; 168(2):1485-9. PubMed ID: 23332896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility Of Heart Type Fatty Acid Binding Protein (H-Fabp) Point Of Care Test In The Early Hours Of Stemi Compared With Troponin-I In Pakistani Population.
    Abbasi WA; Saleem M; Rasheed S; Kiyani AM
    J Ayub Med Coll Abbottabad; 2017; 29(1):107-111. PubMed ID: 28712187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of quantitative heart-fatty acid binding protein assays compared with Cardiodetect(®) in the early detection of acute coronary syndrome.
    Charpentier S; Maupas-Schwalm F; Cournot M; Elbaz M; Ducassé JL; Bottela JM; Lauque D
    Arch Cardiovasc Dis; 2011 Oct; 104(10):524-9. PubMed ID: 22044705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study.
    Tveit SH; Myhre PL; Hoff NJS; Le TM; Seljeflot I; Røysland R; Høiseth AD; Røsjø H; Omland T
    Clin Biochem; 2020 Apr; 78():10-17. PubMed ID: 31899280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of heart fatty-acid binding protein in early hospitalized patients with non ST elevation acute coronary syndrome].
    Trifonov IR; Katrukha AG; Iavelov IS; Averkov OV; Gratsianskiĭ NA
    Kardiologiia; 2003; 43(5):4-8. PubMed ID: 12891232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain.
    Inoue K; Suwa S; Ohta H; Itoh S; Maruyama S; Masuda N; Sugita M; Daida H
    Circ J; 2011; 75(12):2813-20. PubMed ID: 21937835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain.
    Vupputuri A; Sekhar S; Krishnan S; Venugopal K; Natarajan KU
    Indian Heart J; 2015; 67(6):538-42. PubMed ID: 26702681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of a new point-of-care cardiac troponin I test.
    Christ M; Geier F; Blaschke S; Giannitsis E; Khellaf M; Mair J; Pariente D; Scharnhorst V; Semjonow V; Hausfater P
    Clin Chem Lab Med; 2018 Jul; 56(8):1336-1344. PubMed ID: 29630502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.